Medication overuse headache and applicability of the ICHD-II diagnostic criteria: 1-year follow-up study (CARE i protocol)

Cephalalgia

Volumn 29, Issue 2, 2009, Pages 233-243

  Ghiotto, N ^a,b   Sances, G ^a,b   Galli, F ^a,c   Tassorelli, C ^a   Guaschino, E ^a   Sandrini, G ^a   Nappi, G ^a,d  

^a University Centre for Adaptive Disorders and Headache (UCADH)   (Italy)

^b C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

^c Department of Child and Adolescent Neurology Psychiatry and Rehabilitation   (Sweden)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Classification; Follow up; ICHD II; In patient detoxification; MOH

Indexed keywords

ANALGESIC AGENT; ERGOTAMINE; OPIATE; TRIPTAN DERIVATIVE;

ADOLESCENT; ADULT; AGED; ARTICLE; DETOXIFICATION; DISEASE CLASSIFICATION; DRUG INDUCED HEADACHE; FEMALE; HUMAN; INTERNATIONAL CLASSIFICATION OF HEADACHE DISORDER; MAJOR CLINICAL STUDY; MALE; MIGRAINE; TENSION HEADACHE;

ADULT; AGED; ANALGESICS; ERGOTAMINE; FEMALE; FOLLOW-UP STUDIES; HEADACHE DISORDERS, SECONDARY; HUMANS; MALE; MIDDLE AGED; TREATMENT OUTCOME; TRYPTAMINES; YOUNG ADULT;

EID: 58449129169     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1111/j.1468-2982.2008.01712.x     Document Type: Article

References (35)

1. Katsarava Z, Jensen R. Medication-overuse headache: where are we now? Curr Opin Neurol 2007 20 : 326 30.
2. Pascual J, Colás R, Castillo J. Epidemiology of chronic daily headache. Curr Pain Headache Rep 2001 5 : 529 36.
3. Rapoport A, Stang P, Gutterman DL, Cady R, Markley H, Weeks R et al. Analgesic rebound headache in clinical practice: data from a physician survey. Headache 1996 36 : 14 19.
4. Meskunas CA, Tepper SJ, Rapoport AM, Sheftell FD, Bigal ME. Medications associated with probable medication overuse headache reported in a tertiary care headache center over a 15-year period. Headache 2006 46 : 766 72.
5. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988 7 (Suppl 1 96.
6. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders: 2nd edition. Cephalalgia 2004 24 (Suppl. 1 9 160.
7. Silberstein SD, Olesen J, Bousser M-G, Diener H-C, Dodick D, First M et al. The International Classification of Headache Disorders, 2nd edn (ICHD-II) - revision of criteria for 8.2 Medication-overuse headache. Cephalalgia 2005 25 : 460 5.
8. Olesen J, Bousser M-G, Diener H-C, Dodick D, First M, Goadsby PJ et al., Headache Classification Committee. New appendix criteria open for a broader concept of chronic migraine. Cephalalgia 2006 26 : 742 6.
9. Diener HC, Dahlöf CGH. Headache associated with chronic use of substances. In : Olesen J, Tfelt-Hansen P, Welch KMA, eds. The headaches, 2nd edn. Philadelphia : Lippincott, Williams & Wilkins 1999 : 671 878.
10. Krymchantowski AV, Moreira PF. Out-patient detoxification in chronic migraine: comparison of strategies. Cephalalgia 2003 23 : 982 93.
11. Rossi P, Di Lorenzo C, Faroni J, Cesarino F, Nappi G. Advice alone vs. structured detoxification programmes for medication overuse headache: a prospective, randomized, open-label trial in transformed migraine patients with low medical needs. Cephalalgia 2006 26 : 1097 105.
12. Krymchantowski AV, Barbosa JS. Prednisone as initial treatment of analgesic-induced daily headache. Cephalagia 2000 20 : 107 13.
13. Raskin NH. Repetitive intravenous dihydroergotamine as therapy for intractable migraine. Neurology 1986 36 : 995 7.
14. Silberstein SD, Schulman EA, Hopkins MM. Repetitive intravenous DHE in the treatment of refractory headache. Headache 1990 30 : 334 9.
15. Williams DR, Stark RJ. Intravenous lignocaine (lidocaine) infusion for the treatment of chronic daily headache with substantial medication overuse. Cephalalgia 2003 23 : 963 71.
16. Relja G, Granato A, Bratina A, Antonello RM, Zorzon M. Outcome of medication overuse headache after abrupt in-patient withdrawal. Cephalalgia 2006 26 : 589 95.
17. Grazzi L, Andrasik F, D'Amico D, Leone M, Usai S, Kass SJ et al. Behavioral and pharmacologic treatment of transformed migraine with analgesic overuse: outcome at 3 years. Headache 2002 42 : 483 90.
18. Zeeberg P, Olesen J, Jensen R. Efficacy of multidisciplinary treatment in a tertiary referral headache centre. Cephalalgia 2005 25 : 1159 67.
19. Katsarava Z, Muessig M, Dzagnizde A, Fritsche G, Diener HC, Limmroth V. Medication overuse headache: rates and predictors for relapse in a 4-year prospective study. Cephalalgia 2005 25 : 12 15.
20. Fritsche G, Eberl A, Katsarava Z, Limmoroth V, Diener HC. Drug-induced headache: long-term follow-up of withdrawal therapy and persistence of drug misuse. Eur Neurol 2001 45 : 229 35.
21. Sances G, Ghiotto N, Loi M, Guaschino E, Marchioni E, Catarci T, Nappi GA. CARE pathway in medication-overuse headache: the experience of the Headache Centre in Pavia. J Headache Pain 2005 6 : 307 9.
22. Nappi G, Jensen R, Nappi RE, Sances G, Torelli P, Olesen J. Diaries and calendars for migraine. A review. Cephalalgia 2006 26 : 905 16.
23. Mazzi F, Morosini P, De Girolamo G, Lusetti G, Guaraldi GP. SCID-I CV: Edizione Italiana. Florence : O.S. Organizzazioni Speciali 2000.
24. Zeeberg P, Olesen J, Jensen R. Discontinuation of medication overuse in headache patients: recovery of therapeutic responsiveness. Cephalalgia 2006 26 : 1192 8.
25. Zeeberg P, Olesen J, Jensen R. Probable medication-overuse headache - the effect of a 2-month drug-free period. Neurology 2006 66 : 1894 989.
26. Katsarava Z, Fritsche G, Muessig N, Diener HC, Limmroth V. Clinical features of withdrawal headache following overuse of triptans and other headache drugs. Neurology 2001 57 : 1694 8.
27. Bigal ME, Rapoport AM, Sheftell FD, Tepper SJ, Lipton RB. Transformed migraine and medication overuse in a tertiary headache centre - clinical characteristics and treatment outcomes. Cephalalgia 2004 24 : 483 90.
28. Bigal ME, Sheftel FD, Tepper SJ, Rapoport AM. Discontinuation of medication overuse in headache patients: recovery of therapeutic responsiveness. Cephalalgia 2007 27 : 568 9.
29. Saper JR, Lake AE 3rd. Medication overuse headache: type I and type II. Cephalalgia 2006 26 : 1262.
30. Manzoni GC, Granella F, Sandrini G, Cavallini A, Zanferrari C, Nappi G. Classification of chronic daily headache by International Headache Society criteria: limits and new proposals. Cephalalgia 1995 15 : 37 43.
31. Granella F, Farina S, Malferrari G, Manzoni GC. Drug abuse in chronic headache: a clinic-epidemiologic study. Cephalalgia 1987 7 : 15 19.
32. Pini LA, Bigarelli M, Vitale G, Sternieri E. Headaches associated with chronic use of analgesics: a therapeutic approach. Headache 1996 36 : 433 9.
33. Linton-Dahlöf P, Linde M, Dahlöf C. Withdrawal therapy improves chronic daily headache associated with long-term misuse of headache medication: a retrospective study. Cephalalgia 2000 20 : 658 62.
34. Katsarava Z, Limmroth V, Finke M, Diener H, Fritsche G. Rates and predictors for relapse in medication overuse headache: a 1-year prospective study. Neurology 2003 60 : 1682 3.
35. Zidverc-Trajkovic J, Pekmezovic T, Jovanovic Z, Pavlovic A, Mijajlovic M, Radojicic A, Sternic N. Medication overuse headache: clinical features predicting treatment outcome at 1-year follow-up. Cephalalgia 2007 27 : 1219 25.